Profile Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
|T. Rowe Price Associates, Inc.||8.80|
|Capital Research & Management Co. (World Investors)||8.36|
|Fidelity Management & Research Co.||7.86|
|The Vanguard Group, Inc.||6.41|
|Wellington Management Co. LLP||6.01|
|BlackRock Fund Advisors||5.38|
|SSgA Funds Management, Inc.||4.74|
|ClearBridge Investments LLC||3.48|
|Columbia Management Investment Advisers LLC||3.13|
|JPMorgan Investment Management, Inc.||2.96|
|Waddell & Reed Investment Management Co.||1.55|
|Goldman Sachs Asset Management LP||1.22|
|Northern Trust Investments, Inc.||1.07|
|Ivy Investment Management Co.||1.03|